A clinical trial looking at the use and safety of tadalafil for the treatment of Duchenne Muscular Dystrophy in children

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-001194-25

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to test the hypothesis that once daily tadalafil administered orally for 48 weeks lessens the decline in ambulatory ability as measured by the 6MWD compared to placebo in boys with Duchenne muscular dystrophy (DMD).


Critère d'inclusion

  • Duchenne Muscular Dystrophy